Ferroptosis and Necroptosis in the Kidney. Issue 4 (16th April 2020)

• Record Type: Journal Article
• Authors: Belavgeni, Alexia; Meyer, Claudia; Stumpf, Julian; Hugo, Christian; Linkermann, Andreas
• Is Part Of: Cell chemical biology. Volume 27:Issue 4(2020)
• Page Start: 448
• Page End: 462
• Publication Date: 2020-04-16
• Subjects: regulated cell death -- necrotizing vasculitis -- ANCA-associated vasculitis -- acute tubular necrosis -- regulated necrosis -- programmed necrosis -- transplantation -- xenotransplantation; Biochemistry -- Periodicals; 572.05
• DOI: 10.1016/j.chembiol.2020.03.016
• Languages: English
• ISSNs: 2451-9456

Abstract

Abstract : In the last decade, the role of apoptosis in the pathophysiology of acute kidney injury (AKI) and AKI to chronic kidney disease (CKD) progression has been revisited as our understanding of ferroptosis and necroptosis has emerged. A growing body of evidence, reviewed here, ascribes a central pathophysiological role for ferroptosis and necroptosis to AKI, nephron loss, and acute tubular necrosis. We will introduce concepts to the non-cell-autonomous manner of kidney tubular injury during ferroptosis, a phenomenon that we refer to as a "wave of death." We hypothesize that necroptosis might initiate cell death propagation through ferroptosis. The remaining necrotic debris requires effective removal processes to prevent a secondary inflammatory response, referred to as necroinflammation. Open questions include the differences in the immunogenicity of ferroptosis and necroptosis, and the specificity of necrostatins and ferrostatins to therapeutically target these processes to prevent AKI-to-CKD progression and end-stage renal disease. Graphical Abstract: Abstract : Acute kidney injury (AKI) is defined as the rapid loss of renal function. Morphologically and pathophysiologically, acute tubular necrosis appears to be critically involved. Here, we discuss two pathways of regulated necrosis, ferroptosis and necroptosis, as potential therapeutic targets for the treatment of AKI and AKI-to-CKD progression.